1162665-53-3

Basic information

• Product Name: L-Valine, N-(2-cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-, methyl ester
• Synonyms: L-Valine, N-(2-cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-, methyl ester;N-(2-Cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-L-valine methyl ester;(S)-Methyl 2-(2-cyano-N-(3,3-diMethylbutyl)acetaMido)-3,3-diMethylbutanoate
• CAS NO: 1162665-53-3
• Molecular Formula: C16H28N2O3
• Molecular Weight: 296.40512
• Mol File: 1162665-53-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 404.7±30.0 °C(Predicted)
• Appearance: /
• Density: 1.006
• Storage Temp.: 2-8°C
• PKA: 5.43±0.10(Predicted)
• CAS DataBase Reference: L-Valine, N-(2-cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Valine, N-(2-cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-, methyl ester(1162665-53-3)
• EPA Substance Registry System: L-Valine, N-(2-cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-, methyl ester(1162665-53-3)

Safety Data

• Hazardous Substances Data: 1162665-53-3(Hazardous Substances Data)

Usage

General Description

L-Valine, N-(2-cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-, methyl ester is a complex chemical compound with various important applications. L-Valine is an essential amino acid that plays a key role in protein synthesis and muscle repair. The presence of the cyanoacetyl and dimethylbutyl groups in this compound suggests potential pharmaceutical or medicinal applications, while the methyl ester group makes it suitable for use as a chemical intermediate or building block in organic synthesis. L-Valine, N-(2-cyanoacetyl)-N-(3,3-dimethylbutyl)-3-methyl-, methyl ester may have potential uses in the development of pharmaceutical drugs, agrochemicals, or other commercially important products. However,

Upstream product

• 926-36-3 4,4-dimethylpentanal 
• 3850-31-5 methyl tert-leucinate 
• 372-09-8 cyanoacetic acid 

Relevant articles and documents

Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor

Hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus replication. NS5B has no functional equivalent in mammalian cells, and as a consequence is an attractive target for selective inhibition. This paper describes the discovery of a novel family of HCV NS5B non-nucleoside inhibitors inspired by the bioisosterism between sulfonamide and phosphonamide. Systematic structural optimization in this new series led to the identification of IDX375, a potent non-nucleoside inhibitor that is selective for genotypes 1a and 1b. The structure and binding domain of IDX375 were confirmed by X-ray co-crystalisation study.